144 related articles for article (PubMed ID: 37633884)
1. Cervical cancer screening and treatment for PLWHIV: experiences from an innovative program in Nigeria.
Ogunsola OO; Ajayi OA; Ojo TO; Osayi E; Wudiri K; Amoo B; Ayoka-Ikechukwu R; Olumeyan OO; Ifechelobi C; Okonkwo P; Akinro Y
Reprod Health; 2023 Aug; 20(1):125. PubMed ID: 37633884
[TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus-based cervical precancer screening with visual inspection with acetic acid triage to achieve same-day treatments among women living with human immunodeficiency virus infection: test-of-concept study in Ibadan, Nigeria.
Awolude OA; Oyerinde SO; Ayeni AO; Adewole IF
Pan Afr Med J; 2021; 40():48. PubMed ID: 34795828
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic accuracy of cervical cancer screening and screening-triage strategies among women living with HIV-1 in Burkina Faso and South Africa: A cohort study.
Kelly HA; Chikandiwa A; Sawadogo B; Gilham C; Michelow P; Lompo OG; Omar T; Zan S; Magooa P; Segondy M; Nagot N; Meda N; Delany-Moretlwe S; Mayaud P;
PLoS Med; 2021 Mar; 18(3):e1003528. PubMed ID: 33661957
[TBL] [Abstract][Full Text] [Related]
4. AVIVA: a telehealth tool to improve cervical cancer screening in resource-constrained settings.
Ogunsola OO; Olawepo JO; Ajayi O; Osayi E; Akinro YT; Ifechelobi C; Chigbu C; Okonkwo P; Ezeanolue EE
BMJ Glob Health; 2023 Jul; 8(7):. PubMed ID: 37433694
[TBL] [Abstract][Full Text] [Related]
5. Cervical cancer screening and treatment, HIV infection, and age: Program implementation in seven regions of Namibia.
Korn AK; Muzingwani L; O'Bryan G; Ensminger A; Boylan AD; Kafidi EL; Kashali M; Ashipala L; Nitschke AM; Dziuban EJ; Forster N; Eckert LO; O'Malley G
PLoS One; 2022; 17(2):e0263920. PubMed ID: 35171941
[TBL] [Abstract][Full Text] [Related]
6. Comparative Assessment of p16/Ki-67 Dual Staining Technology for cervical cancer screening in women living with HIV (COMPASS-DUST)-Study protocol.
Okunade KS; Badmos KB; Okoro AC; Ademuyiwa IY; Oshodi YA; Adejimi AA; Awolola NA; Ozonu O; Adelabu H; Olorunfemi G; Akanmu AS; Banjo AA; Anorlu RI; Berek JS
PLoS One; 2023; 18(1):e0278077. PubMed ID: 36701329
[TBL] [Abstract][Full Text] [Related]
7. Cervical cancer screening outcomes in public health facilities in three states in Nigeria.
Lawson O; Ameyan L; Tukur Z; Dunu S; Kerry M; Okuyemi OO; Yusuf Z; Fasawe O; Wiwa O; Hebert KS; Joseph JT; Nwokwu UE; Okpako O; Chime CI
BMC Public Health; 2023 Sep; 23(1):1688. PubMed ID: 37658293
[TBL] [Abstract][Full Text] [Related]
8. High Prevalence of Cervical High-Grade Lesions and High-Risk Human Papillomavirus Infections in Women Living with HIV: A Case for Prioritizing Cervical Screening in This Vulnerable Group.
Gupta R; Hussain S; Hariprasad R; Dhanasekaran K; Verma S; Agarwal V; Sandeep ; Parveen S; Kaur A; Verma CP; Amita ; Dwivedi R; Singh S; Gupta S
Acta Cytol; 2022; 66(6):496-506. PubMed ID: 35760059
[TBL] [Abstract][Full Text] [Related]
9. Accuracy of visual inspection with acetic acid to detect cervical cancer precursors among HIV-infected women in Kenya.
Huchko MJ; Sneden J; Sawaya G; Smith-McCune K; Maloba M; Abdulrahim N; Bukusi EA; Cohen CR
Int J Cancer; 2015 Jan; 136(2):392-8. PubMed ID: 24889387
[TBL] [Abstract][Full Text] [Related]
10. A randomized trial comparing the diagnostic accuracy of visual inspection with acetic acid to Visual Inspection with Lugol's Iodine for cervical cancer screening in HIV-infected women.
Huchko MJ; Sneden J; Zakaras JM; Smith-McCune K; Sawaya G; Maloba M; Bukusi EA; Cohen CR
PLoS One; 2015; 10(4):e0118568. PubMed ID: 25849627
[TBL] [Abstract][Full Text] [Related]
11. Knowledge, attitude, and practice of cervical cancer screening among women living with HIV in the Kilimanjaro region, northern Tanzania.
Kimondo FC; Kajoka HD; Mwantake MR; Amour C; Mboya IB
Cancer Rep (Hoboken); 2021 Oct; 4(5):e1374. PubMed ID: 33739611
[TBL] [Abstract][Full Text] [Related]
12. Costs and cost-effectiveness of cervical cancer screening strategies in women living with HIV in Burkina Faso: The HPV in Africa Research Partnership (HARP) study.
Devine A; Vahanian A; Sawadogo B; Zan S; Bocoum FY; Kelly H; Gilham C; Nagot N; Ong JJ; Legood R; Meda N; Miners A; Mayaud P;
PLoS One; 2021; 16(3):e0248832. PubMed ID: 33765011
[TBL] [Abstract][Full Text] [Related]
13. Comparative evaluation of human papilloma virus-DNA test verses colposcopy as secondary cervical cancer screening test to triage screen positive women on primary screening by visual inspection with 5% acetic acid.
Pimple S; Shastri SS
Indian J Cancer; 2014; 51(2):117-23. PubMed ID: 25104191
[TBL] [Abstract][Full Text] [Related]
14. Performance of visual inspection with acetic acid and human papillomavirus testing for detection of high-grade cervical lesions in HIV positive and HIV negative Tanzanian women.
Dartell MA; Rasch V; Iftner T; Kahesa C; Mwaiselage JD; Junge J; Gernow A; Ejlersen SF; Munk C; Kjaer SK
Int J Cancer; 2014 Aug; 135(4):896-904. PubMed ID: 24391021
[TBL] [Abstract][Full Text] [Related]
15. Screening for cervical cancer among HIV-positive and HIV-negative women in Cameroon using simultaneous co-testing with careHPV DNA testing and visual inspection enhanced by digital cervicography: Findings of initial screening and one-year follow-up.
Cholli P; Bradford L; Manga S; Nulah K; Kiyang E; Manjuh F; DeGregorio G; Ogembo RK; Orock E; Liu Y; Wamai RG; Sheldon LK; Gona PN; Sando Z; Welty T; Welty E; Ogembo JG
Gynecol Oncol; 2018 Jan; 148(1):118-125. PubMed ID: 29153541
[TBL] [Abstract][Full Text] [Related]
16. DETERMINANT FACTORS OF VISUAL INSPECTION WITH ACETIC ACID (VIA) POSITIVE LESIONS AMONG HIV POSITIVE WOMEN IN MEKELLE HOSPITAL, NORTHERN ETHIOPIA: A CASE CONTROL STUDY.
Gessesse Z; Tadesse Z; Alemayehu M; Hiruye A; Getachew Y; Derbew M; Mariam DH; Mammo D; Eva K; Yebyo H; Michael HG
Ethiop Med J; 2015 Jul; Suppl 2():17-24. PubMed ID: 26591279
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the Accuracy of Papanicolaou Test Cytology, Visual Inspection With Acetic Acid, and Visual Inspection With Lugol Iodine in Screening for Cervical Neoplasia in Southeast Nigeria.
Egede J; Ajah L; Ibekwe P; Agwu U; Nwizu E; Iyare F
J Glob Oncol; 2018 Sep; 4():1-9. PubMed ID: 30241249
[TBL] [Abstract][Full Text] [Related]
18. Performance of cervical cancer screening and triage strategies among women living with HIV in China.
Duan R; Zhao X; Zhang H; Xu X; Huang L; Wu A; Li L; Qiao Y; Zhao F
Cancer Med; 2021 Sep; 10(17):6078-6088. PubMed ID: 34342174
[TBL] [Abstract][Full Text] [Related]
19. Acting on the call for cervical cancer elimination: Planning tools for low- and middle- income countries to increase the coverage and effectiveness of screening and treatment.
Herrick T; Thomson KA; Shin M; Gannon S; Tsu V; de Sanjosé S
BMC Health Serv Res; 2022 Oct; 22(1):1246. PubMed ID: 36241993
[TBL] [Abstract][Full Text] [Related]
20. Early experiences in integrating cervical cancer screening and treatment into HIV services in Zomba Central Hospital, Malawi.
Pfaff C; Singano V; Akello H; Amberbir A; Berman J; Kwekwesa A; Matengeni A; Banda V; Msonko J; Speight C; Kabeya BM; van Oosterhout JJ
Malawi Med J; 2018 Sep; 30(3):211-214. PubMed ID: 30627358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
